Metraipolis › archive › dc_7ef8a3bf8d0e

A true theranostic pair - 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer — Europe PMC PMID:41217470

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41217470
DOI: 10.1007/s00259-[numero omesso]-y
License (as archived): solo-consultazione
Archived: 2026-11-08T15:54:07.897Z
SHA-256 of the archived text: 14e3e0da86dbee5409a59bae5a86e151692823e55493cd9ce813ecbef99f8c90
Stable URL of this page: https://metraipolis.com/documento/dc_7ef8a3bf8d0e

How to cite

A true theranostic pair - 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer — Europe PMC PMID:41217470 — Europe PMC (en), https://europepmc.org/article/MED/41217470 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ef8a3bf8d0e (Metraipolis archive dc_7ef8a3bf8d0e, sha256 14e3e0da86dbee5409a59bae5a86e151692823e55493cd9ce813ecbef99f8c90)

BibTeX

@misc{dc7ef8a3bf8d0e,
  title = {A true theranostic pair - 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer — Europe PMC PMID:41217470},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41217470},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ef8a3bf8d0e; sha256 14e3e0da86dbee5409a59bae5a86e151692823e55493cd9ce813ecbef99f8c90},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41217470. Agents can read the archived copy with the MCP tool read_document.